Forming a network of clinicians and scientists

The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.

Photo: NASA

.

Find the latest information on the upcoming Nordic AML Meeting in Bergen 10-12 September 2025 here.

News from NAMLG

[News? Please, let us know via namlgewg@gmail.com.]

Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in AML in the Prospective VenEx Trial

Results from the Finnish VenEx trial (NCT04267081) have now been published in Blood. You can find the publication by using this link.

Upcoming events

[Have an event? Please, let us know via namlgewg@gmail.com.]

NAMLG Lunch Meeting in Munich

For Nordic AML physicians attending the Acute Leukemia Symposium ISALXIX in Munich 16-19th March 2025, You are cordially invited to a NAMLG Lunch Meeting in on Monday March 17th, 12.00-14.00. […]

Find out more »

The c-myc Single Cell Satellite Seminar

The newly established Jebsen Centre for Myeloid Blood Cancer (c-myc) will have their first Annual c-myc Seminar as a full-day satellite to CCBIO’s 13th Annual Symposium and will showcase recent […]

Find out more »

The 13th CCBIO Annual Symposium

CCBIO has the pleasure of inviting you to the 13th CCBIO Annual Symposium May 13-14, and now, PREFINAL PROGRAM is available. To participate, please register within April 1. There will be a strong scientific […]

Find out more »

AML Course Day 10 September 2025

The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current […]

Find out more »

Nordic AML Meeting 11-12 September 2025

Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.

Find out more »

All Upcoming Events

All

Click here to add your own text